Overcoming ADC Resistance: Construction and Preclinical Applications of Enhertu-Resistant Models
April 15, 2026
Webinar Outline:
• Construction and validation of an Enhertu-induced resistant CDX model
• Investigation of underlying resistance mechanisms
• Characterization of a primary Enhertu-resistant PDX model
For more information, please contact sales@gempharmatech.com
Previous:N/A


